Description: Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pediatric medicines in China. It offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine. The company markets its products through a network of agents and sales terminals. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. is headquartered in Guangzhou, China.
Home Page: www.honz.com.cn
Dongshan Square
Guangzhou,
China
Phone:
86 20 8732 4060
Officers
| Name | Title |
|---|---|
| Mr. Jiangtao Hong | Pres |
| Ms. Liping Hong | Vice Chairman & VP |
| Mr. Dexin Lin | VP & Board Sec. |
| Mr. Yong Wang | Assistant to the Chairman |
| Mr. Dongxiong Hong | Mang. of the Purchasing Department & Non-Employee Supervisor |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.485 |
| Price-to-Sales TTM: | 6.3118 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 872 |